Evaluation of chemotherapy‐induced cutaneous side effects in cancer patients

Saadet, Elif Demirci; Tek, Ibrahim

doi:10.1111/ijd.16361

Cited by 5 publications

(2 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These data differ from our findings. Another study [ 50 ] indicates a prevalence of 35.3% for the hand-foot syndrome, consistent with the present investigation. They also found 14.1% of xerosis, and 12% of nail changes, which do not match with our findings.…”

Section: Discussionsupporting

confidence: 93%

Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross‐sectional study

Veiga‐Seijo,

Pertega‐Diaz,

Perez‐Lopez

et al. 2023

Journal of Foot and Ankle Research

View full text Add to dashboard Cite

Background Chemotherapy is one of the most widely used therapies for breast cancer, triggering important repercussions on people’s quality of life. However, little research has been undertaken about podiatric adverse effects. This study aimed was to determine the prevalence of podiatric pathology developed in people with breast cancer who receive chemotherapy. Methods Observational, descriptive, and cross-sectional study was conducted in the Oncology service of the A Coruña University Hospital (northwest Spain). People with breast cancer and undergoing chemotherapy treatment of legal age (≥ 18), who signed the informed consent (n = 117) were included. Sociodemographic, comorbidity, disease and foot health variables, as well as two self-administered questionnaires (Foot Health Status Questionnaire and Foot Function Index) were studied. The current ethical-legal aspects were followed. Results Foot health problems were highly prevalent, highlighting nail color changes (59.8%), onychocryptosis (39.7%), xerosis (62.4%), plantar fasciitis (12.8%), and neuropathic symptoms (75.2%). Some foot pain was presented in 77.8% of the sample, predominantly at nail level (15.4%) or sole of the foot and nail (14.5%). Most participants described their foot health as fair or poor (56.4%) and felt limited in walking (65.8%). The lowest score for the Foot Health Status Questionnaire was footwear (30.6(33.5)). Conclusions Foot health adverse effects represent worrisome problems in women with breast cancer undergoing chemotherapy, due to their high prevalence and negative implications on quality of life. These problems are critical as they may have implications for stopping or reducing chemotherapy. All these results call for the development of more research to contribute to the care and wellbeing of people with cancer who receive treatments such as chemotherapy. Thus, this line of research is a new path to be developed by the podiatry community.

show abstract

Section: Discussionsupporting

confidence: 93%

Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross‐sectional study

Veiga‐Seijo,

Pertega‐Diaz,

Perez‐Lopez

et al. 2023

Journal of Foot and Ankle Research

View full text Add to dashboard Cite

show abstract

“…These data differ from our ndings. Another study [39] indicates a prevalence of 35.3% for the hand-foot syndrome, consistent with the present investigation. They also found 14.1% of xerosis, and 12% of nail changes, which do not coincide with our ndings.…”

Section: Structural Skin Nail Conditions and Peripheral Neuropathysupporting

confidence: 93%

Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study. Working towards a holistic care approach.

Veiga-Seijo

Pértega-Díaz

Perez-Lopez

et al. 2023

Preprint

View full text Add to dashboard Cite

Background. Chemotherapy is one of the most widely used therapies for breast cancer, triggering important repercussions on people’s quality of life. However, little research has been undertaken about podiatric adverse effects. This study aimed was to determine the prevalence of podiatric pathology developed in people with breast cancer who receive chemotherapy. Methods. Observational, descriptive, and cross-sectional study was conducted in the Oncology service of the A Coruña University Hospital (northwest Spain). People with breast cancer and undergoing chemotherapy treatment of legal age (≥18), who signed the informed consent (n=117) were included. Sociodemographic, comorbidity, disease and foot health variables, as well as two self-administered questionnaires (Foot Health Status Questionnaire and Foot Function Index) were studied. The current ethical-legal aspects were followed. Results. Foot health problems were highly prevalent, highlighting nail color changes (60.3%), onychocryptosis (39.7%), xerosis (62.1%), plantar fasciitis (12.9%), and neuropathic symptoms (75.2%). Some foot pain was presented in 77.8% of the sample, predominantly at nail level (15.4%) or sole of the foot and nail (14.5%). Most participants described their foot health as fair or poor (56.4%) and felt limited in walking (65.8%). The lowest score for the Foot Health Status Questionnaire was footwear (32.5±42.1). Conclusions. Foot health adverse effects represent worrisome problems in women with breast cancer undergoing chemotherapy, due to their high prevalence and negative implications on quality of life. These problems are critical as they may have implications for stopping or reducing chemotherapy. All these results call for the development of more research to contribute to the care and wellbeing of people with cancer who receive treatments such as chemotherapy. Thus, this line of research is a new path to be developed by the podiatry community.

show abstract

Stem Cell Therapies for the Treatment of Radiation and Chemotherapy Side Effects

Deptula,

Zawrzykraj,

Czerwiec

et al. 2024

Reference Module in Biomedical Sciences

View full text Add to dashboard Cite

Evaluation of chemotherapy‐induced cutaneous side effects in cancer patients

Cited by 5 publications

References 26 publications

Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross‐sectional study

Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross‐sectional study

Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study. Working towards a holistic care approach.

Stem Cell Therapies for the Treatment of Radiation and Chemotherapy Side Effects

Contact Info

Product

Resources

About